Sanofi and King Salman Humanitarian Aid and Relief Centre sign memorandum to advance access to essential vaccines in humanitarian settings
•Sanofi and KSrelief will work together to identify ways to improve access to essential vaccines in countries with limited immunization services or facing humanitarian and public health challenges.•The cooperation will draw on KSrelief’s experience delivering humanitarian assistance and Sanofi’s expertise in vaccines and infectious disease prevention.•The memorandum identifies knowledge sharing,…
Sanofi and the King Salman Humanitarian Aid and Relief Centre (KSrelief) have entered into a memorandum of cooperation to expand access to essential vaccines and support infectious disease prevention in humanitarian settings. The partnership combines KSrelief's humanitarian experience with Sanofi's expertise in vaccines and infectious disease prevention.
The agreement focuses on two key areas: improving access to essential vaccines in humanitarian settings and leveraging Saudi Arabia's capabilities to support global health security. KSrelief's humanitarian aid programs, staffed by trusted local partners, will be the delivery mechanism for any vaccine support. This aligns with United Nations Sustainable Development Goals and broader health security initiatives.
Saudi Arabia's role in regional and global health security will also be bolstered through knowledge sharing, capacity building, and potential local vaccine manufacturing partnerships with companies like Sanofi. Joint working groups will evaluate proposed initiatives and devise implementation plans.
The memorandum highlights Sanofi's commitment to protecting people from preventable diseases and KSrelief's dedication to strengthening local health capabilities. The collaboration exemplifies the strategic partnership between France and Saudi Arabia, as both nations prioritize public health and health security.
Rewritten by urgent.news; may contain errors — check the original.
Source: saudigazette.com.sa